Unregistered sales and modifications of equity under 8-K Items 3.02/3.03.
Leef Brands Inc. issued 33,146,842 warrants of warrant.
“Each Unit consisted of one Common Share of the Company, no par value, and one common share purchase warrant. Each warrant entitles the holder to acquire one additional Common Share of the Company at an exercise price of CN$0.30 per share for a period of 24 months from the date of issuance.”
Leef Brands Inc. issued 33,146,842 Common Share Units of unit to Mindset Capital, existing shareholders, new strategic investors for CN$0.25 per Unit.
“On May 18, 2026, Leef Brands, Inc., a British Columbia corporation (the “Company”), completed its previously announced financing, pursuant to which the Company raised aggregate gross proceeds of approximately US$9.3 million. In connection with the closings pursuant to the financing, the Company issued an aggregate of 33,146,842 Common Share Units (each, a “Unit”) at a price of CN$0.25 per Unit.”
International Land Alliance Inc. issued 48,125 shares of Company common stock of warrant to accredited investor for convertible promissory note in the aggregate principal amount up to $385,000.
“On May 19, 2026, International Land Alliance, Inc., a Wyoming corporation (“Company”) entered into a Securities Purchase Agreement transaction with an accredited investor (“Investor”) pursuant to which the Company issued to Investor a convertible promissory note in the aggregate principal amount up to $385,000 (“Note”) and a warrant to purchase 48,125 shares of Company common stock (“Warrant”).”
International Land Alliance Inc. issued 48,125 shares of Company common stock of convertible note to accredited investor for convertible promissory note in the aggregate principal amount up to $385,000.
“On May 19, 2026, International Land Alliance, Inc., a Wyoming corporation (“Company”) entered into a Securities Purchase Agreement transaction with an accredited investor (“Investor”) pursuant to which the Company issued to Investor a convertible promissory note in the aggregate principal amount up to $385,000 (“Note”) and a warrant to purchase 48,125 shares of Company common stock (“Warrant”).”
Remora Capital Corp issued 440,241.448 shares of common stock of common stock to investors for aggregate offering price of $4,376,000.
“On June 1, 2026, Remora Capital Corporation (the “Company”) issued 440,241.448 shares of common stock (the “Shares”) of the Company for an aggregate offering price of $4,376,000.”
QUANTUM CORP /DE/ issued 10,615,712 shares of common stock to certain accredited investors for $9.42 per share.
“the Company, in a private placement (the “Private Placement”), agreed to issue and sell to the Investors an aggregate of 10,615,712 shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), at a price of $9.42 per share, for aggregate gross proceeds to the Company of approximately $100.0 million.”
PEABODY ENERGY CORP issued convertible note to initial purchasers for $250 million in aggregate principal amount.
“additional $25 million in aggregate principal amount of the Notes (together with the “Initial Notes,” the “Notes”), bringing the total aggregate principal amount of the Notes to $250 million. On June 2, 2026, the Company completed the private offering of the Notes. The Notes are senior unsecured obligations of the Company. The net proceeds from this offering were”
ESAB Corp issued 1,254,255 shares of its common stock, par value $0.001 per share of common stock to certain institutional investors for aggregate gross proceeds of approximately $143.0 million.
“(ii) 1,254,255 shares (the “ Common Shares ”) of its common stock, par value $0.001 per share (the “ Common Stock ”), in accordance with that certain Common Stock Purchase Agreement dated February 2, 2026 between the Company and certain institutional investors thereto for aggregate gross proceeds of approximately $143.0 million”
ESAB Corp issued 175,000 shares of its 6.50% Series A Mandatory Convertible Preferred Stock, par value $0.001 per share of preferred stock to certain institutional investors for aggregate gross proceeds of approximately $175.0 million.
“the Company completed the previously announced private placements of (i) 175,000 shares (the “ Preferred Shares ”) of its 6.50% Series A Mandatory Convertible Preferred Stock, par value $0.001 per share, pursuant to that certain Preferred Stock Purchase Agreement dated February 2, 2026, between the Company and certain institutional investors thereto for aggregate gross proceeds of approximately $175.0 million”
Greenpro Capital Corp. issued 28,949 shares of common stock to Lee Chong Kuang for $1.7272 per share.
“On May 29, 2026, Greenpro Capital Corp. (the “Company”) entered into a subscription agreement (the “Subscription Agreement”) with its Chief Executive Officer, President and Director, Mr. Lee Chong Kuang, (the “Purchaser”) providing for the private placement of 28,949 shares of the Company’s common stock, par value $0.0001 (the “Common Stock”), at a per share purchase price of $1.7272 (the “Offering”) for aggregate gross proceeds of $50,000.”
Tempest Therapeutics, Inc. issued 2,344,828 shares of warrant to holder of existing warrants for cash exercise of 1,172,414 shares at $1.73 per share, aggregate gross proceeds approx $2.0 million.
“Pursuant to the Inducement Letter, the holder agreed to exercise for cash the Existing Warrants to purchase an aggregate of 1,172,414 shares of the Company’s common stock at a reduced exercise price of $1.73 per share in consideration of the Company’s agreement to issue to the holder a new unregistered common stock purchase warrant (the “ New Warrant ”) to purchase up to 2,344,828 shares of common stock.”
OCEANFIRST FINANCIAL CORP issued a warrant to purchase approximately 11.4 million shares of NVCE Stock of warrant to Warburg Pincus LLC for part of $225 million investment, no separate consideration mentioned.
“Investment Agreement On the Closing Date, OceanFirst (a) issued and sold to affiliates of funds managed by Warburg Pincus LLC (“ Warburg ”), for an aggregate purchase price of $225 million, approximately (i) 9.5 million shares of OceanFirst Common Stock, at $19.76 per share of OceanFirst Common Stock and (ii) 1,812 shares of a new class of OceanFirst non-voting,”
OCEANFIRST FINANCIAL CORP issued 1,812 shares of a new class of OceanFirst non-voting, common-equivalent stock (“ NVCE Stock ”) representing the economic equivalent of approximately 1.8 million of preferred stock to Warburg Pincus LLC for $225 million aggregate purchase price.
“Investment Agreement On the Closing Date, OceanFirst (a) issued and sold to affiliates of funds managed by Warburg Pincus LLC (“ Warburg ”), for an aggregate purchase price of $225 million, approximately (i) 9.5 million shares of OceanFirst Common Stock, at $19.76 per share of OceanFirst Common Stock and (ii) 1,812 shares of a new class of OceanFirst non-voting,”
OCEANFIRST FINANCIAL CORP issued approximately 9.5 million shares of OceanFirst Common Stock of common stock to Warburg Pincus LLC for $225 million aggregate purchase price.
“On the Closing Date, OceanFirst (a) issued and sold to affiliates of funds managed by Warburg Pincus LLC (“ Warburg ”), for an aggregate purchase price of $225 million, approximately (i) 9.5 million shares of OceanFirst Common Stock, at $19.76 per share of OceanFirst Common Stock”
Jefferies Credit Partners BDC Inc. issued 622,093.540 shares of common stock to certain third-party investors for $8,941,817.
“therefor: Date of Unregistered Sale Amount of Shares NAV per Share Consideration As of May 1, 2026 (number of Shares finalized on May 27, 2026) 622,093.540 $ 14.37375 $ 8,941,817 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto”
Weatherford International plc issued up to a total of 818,604 Ordinary Shares of common stock to Advent-NCS Acquisition L.P..
“Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, upon consummation of the Merger, Advent, depending on whether it elects all stock or a mix of cash and stock, could receive up to a total of 818,604 Ordinary Shares.”
DISCIPLINED GROWTH ACQUISITION Corp issued 1,100,000 founder shares of common stock to the at-risk capital investors for aggregate purchase price of approximately $4,000, or approximately $0.004 per share.
“the at-risk capital investors purchased 1,100,000 founder shares pursuant to the Subscription Agreements (of which, 150,000 founder shares were purchased by the Maxim individuals and 950,000 founder shares were purchased by the third-party investors) for an aggregate purchase price of approximately $4,000”
DISCIPLINED GROWTH ACQUISITION Corp issued 5,750,000 Class B ordinary shares of common stock to the Sponsor for aggregate purchase price of $25,000, or approximately $0.004 per share.
“the Sponsor acquired from the Company an aggregate of 5,750,000 Class B ordinary shares of the Company, par value $0.0001 per share (the “founder shares”), for an aggregate purchase price of $25,000, or approximately $0.004 per share”
DISCIPLINED GROWTH ACQUISITION Corp issued 345,000 units of unit to the Sponsor, Maxim and/or its designees and at-risk capital investors for $10.00 per Private Placement Unit for an aggregate purchase price of $3,450,000.
“the Company completed the private sale of an aggregate of 345,000 units (the “Private Placement Units”) to the Sponsor, Maxim and/or its designees and at-risk capital investors at a price of $10.00 per Private Placement Unit for an aggregate purchase price of $3,450,000”
CitroTech Inc. issued 467,012 shares of preferred stock to TC Special Investments LLC.
“agreed to issue 467,012 shares of Series C Preferred Stock to TC Special Investments LLC (“TCSI”) on the date that is 18 months after closing”
CitroTech Inc. issued 103,558 shares of preferred stock to BoltRock Holdings, LLC.
“At closing, the Company issued 103,558 shares of Series C Convertible Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”), to BoltRock Holdings, LLC (“BRH”),”
Wheeler Real Estate Investment Trust, Inc. issued 142,800 shares of its common stock of common stock to an unaffiliated holder of the Company’s securities (the "Investor") for no cash proceeds.
“On May 28, 2026 Wheeler Real Estate Investment Trust, Inc. (the “Company”) agreed to issue 142,800 shares of its common stock, $0.01 par value per share (the “Common Stock”), to an unaffiliated holder of the Company’s securities (the “Investor”) in exchange for 2,800 shares of the Company’s Series D Cumulative Convertible Preferred Stock (the “Series D Preferred Stock”) and 5,600 shares of the Company's Series B Convertible Preferred Stock”
ExchangeRight Income Fund issued 34,106 of common stock to accredited investors for $1,000,000 gross proceeds.
“506(c) of Regulation D promulgated thereunder. The following table details the shares sold: Number of Gross Share Class Shares Sold Proceeds * Class ER-A Common Shares 34,106 $ 1,000,000 Forward-Looking Statements Certain statements contained in this Current Report on Form 8-K other than historical facts may be considered “forward-looking statements,” and, as”
System1, Inc. issued 39,250 shares of Series A Cumulative Convertible Preferred Stock of preferred stock to Participating Lenders for exchange for a portion of the Existing Loans; aggregate initial stated value of $39.3 million.
“the issuance of 39,250 shares of Series A Cumulative Convertible Preferred Stock (the “Preferred Shares”) to the Participating Lenders, with an aggregate initial stated value of $39.3 million (the “Share Consideration”)”
Optimum Communications, Inc. issued Preferred Units having an initial stated value of $300 million of preferred stock to certain institutional accredited investors for aggregate purchase price of $300 million.
“On May 29, 2026, Unsub Topco, an indirect wholly owned subsidiary of Optimum, sold to certain institutional accredited investors newly issued Series A Preferred Units of Unsub Topco (the “Preferred Units”) having an initial stated value of $300 million for an aggregate purchase price of $300 million”
Eloxx Pharmaceuticals, Inc. issued 2,500,000 shares of warrant to such investors.
“On May 27, 2026, such investors exchanged 2,500,000 shares of Common Stock issued in the Prefunded Warrant Exercise for prefunded warrants to purchase an equal number of shares of Common Stock”
Eloxx Pharmaceuticals, Inc. issued 2,500,000 shares of common stock to certain of the investors.
“On April 27, 2026, certain of the investors exercised pre-funded warrants to purchase an aggregate of 2,500,000 shares of Common Stock”
Eloxx Pharmaceuticals, Inc. issued 54,076,677 shares of warrant to the investors party thereto.
“the Company issued and sold prefunded warrants to purchase an aggregate of 54,076,677 shares of common stock”
Lumentum Holdings Inc. issued approximately 5.0 million shares of common stock to certain holders of its outstanding 0.50% Convertible Senior Notes due 2028 for approximately $650.4 million principal amount of the Notes.
“On May 29, 2026, Lumentum Holdings Inc. (the “Company”) entered into separate privately-negotiated exchange agreements (the “Exchange Agreements”) with certain holders of its outstanding 0.50% Convertible Senior Notes due 2028 (the “Notes”), pursuant to which the Company will deliver an aggregate of approximately 5.0 million shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) in exchange for approximately $650.4 million principal amount of the Notes (the “Exchange Transactions”) and related conversion value in excess of the principal amount thereof.”
FortuneX Acquisition Corp issued 260,000 Units of unit to FortuneX Investment Partners Limited (the Sponsor) for $10.00 per Private Unit, generating aggregate gross proceeds of $2,600,000.
“Simultaneously with the consummation of the IPO, the Company consummated a private placement (the “Private Placement”) with the Sponsor for 260,000 Units (the “Private Units”) at a price of $10.00 per Private Unit, generating aggregate gross proceeds of $2,600,000.”
Wellgistics Health, Inc. issued warrants to purchase shares of the Company’s common stock of warrant to certain accredited investors for $7.50 per share.
“The PIPE Warrants are exercisable for shares of Common Stock at an exercise price of $7.50 per share”
Wellgistics Health, Inc. issued in the aggregate principal amount of $21,132,812.50 of convertible note to certain accredited investors for aggregate cash purchase price of $16,906,250.
“shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) (the “PIPE Warrants”). The Notes are being issued for an aggregate cash purchase price of $16,906,250, reflecting a 20% original issue discount, before deducting placement agent fees and offering expenses. The closing of the offering occurred on May 27, 2026 (the “Closing”).”
Calidi Biotherapeutics, Inc. issued up to 17,391,304 (unvested) shares of common stock of warrant to an accredited investor (the "Holder") for exercise price of $0.23.
“On May 28, 2026, Calidi Biotherapeutics, Inc. (the “Company”) issued an amended and restated warrant (the “Warrant”) to purchase up to 17,391,304 (unvested) shares of common stock of the Company, par value $0.0001 per share (the “Common Stock”), with an exercise price of $0.23 to an accredited investor (the “Holder”) in a private placement transaction.”
CID Holdco, Inc. issued convertible note to the Holder for original principal amount of $287,500.
“Form 8-K is incorporated herein by reference. As described in Item 2.03 above, on May 29, 2026, the Company issued the Note to the Holder with an original principal amount of $287,500. The Note is convertible into shares of Common Stock in accordance with its terms, as described above. The Note and securities issued in connection with the Second Required”
Momentus Inc. issued pre-funded warrants to purchase up to 768,580 shares of Common Stock of warrant to institutional investors for $8.50 per share minus the $0.00001 exercise price per share of the Pre-Funded Warrant.
““Securities Purchase Agreement”) with institutional investors (the “Investors”) for a private placement of (i) 2,173,420 shares of the Company’s Class A common stock, par value $0.00001 per share (the “Common Stock”), for $8.50 per share and (ii) pre-funded warrants to purchase up to 768,580 shares of Common Stock (the “Pre-Funded Warrants” and, together with”
Momentus Inc. issued 2,173,420 shares of the Company’s Class A common stock, par value $0.00001 per share of common stock to institutional investors for $8.50 per share.
“On May 26, 2026, Momentus Inc., a Delaware corporation (“Momentus” or the “Company”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with institutional investors (the “Investors”) for a private placement of (i) 2,173,420 shares of the Company’s Class A common stock, par value $0.00001 per share (the “Common Stock”), for $8.50 per share”
DigitalBridge Group, Inc. issued 2,358,601 shares of common stock.
“On May 28, 2026 2,358,601 shares of class A common stock were issued in satisfaction of a redemption request by an OP unit holder.”
TREASURE GLOBAL INC issued common stock to Legacy Trustee Berhad for $1,200,000.
“organized and existing under the laws of Malaysia (the “Investor”), pursuant to which the Company agreed to issue and sell, and the Investor agreed to purchase, an aggregate of $1,200,000 of shares of the Company’s common stock (the “Shares”) in a private placement conducted in reliance on Regulation S of the Securities Act of 1933, as amended (the "Securities”
FARADAY FUTURE INTELLIGENT ELECTRIC INC. issued increase in the number of authorized shares of common stock, par value $0.0001 per share, of the Company from 312,285,439 shares to 452,813,887 shares of common stock.
“On May 27, 2026, Faraday Future Intelligent Electric Inc. (the “Company”) filed an amendment (the “Certificate of Amendment”) to the Company’s Third Amended and Restated Certificate of Incorporation (as amended, the “Charter”) with the office of the Secretary of State of the State of Delaware (the “Delaware SOS”) to effect (i) an increase in the number of authorized shares of common stock, par value $0.0001 per share, of the Company (“FFAI Common Stock”) from 312,285,439 shares to 452,813,887 shares”
CERO THERAPEUTICS HOLDINGS, INC. issued convertible note to SRX Health Solutions, Inc. for $750,000.
“On May 28, 2026, CERo Therapeutics Holdings, Inc., a Delaware corporation (the “Company”) issued and sold a convertible promissory note for a purchase price of $750,000, having a principal face value of $937,500 (the “Note”) to SRX Health Solutions, Inc. (“Lender”).”
Star Mountain Lower Middle-Market Capital Corp issued 45,586.975 Class I shares of common stock to accredited investors for $1,064,000.00.
“Star Mountain Lower Middle-Market Capital Corp. (the "Company") issued and sold 45,586.975 Class I shares of the Company’s common stock, par value $0.001 per share (the "Common Stock"), on May 29, 2026, for an aggregate offering price of $1,064,000.00.”
Lord Abbett Private Credit Fund S issued approximately 102,024 of common stock to accredited investors for $24.70 per Common Share.
“As of May 1, 2026, Lord Abbett Private Credit Fund S (“we”, the “Company” or the “Fund”), issued and sold approximately 102,024 of the Company’s common shares of beneficial interest (the “Common Shares”) for an aggregate offering price of approximately $2.5 million, reflecting a purchase price of $24.70 per Common Share”
Lord Abbett Private Credit Fund issued approximately 379,963 of the Company's common shares of common stock to accredited investors for aggregate offering price of approximately $9.4 million, reflecting a purchase price of $24.78 per Common Share.
“As of May 1, 2026, Lord Abbett Private Credit Fund (“we”, the “Company” or the “Fund”) issued and sold approximately 379,963 of the Company’s common shares of beneficial interest (the “Common Shares”) for an aggregate offering price of approximately $9.4 million, reflecting a purchase price of $24.78 per Common Share (with the final number of Common Shares being determined on May 26, 2026).”
Classover Holdings, Inc. issued convertible note to the Buyer for $600,000 principal amount.
“Concurrently with the entering into the Amendment, the Company sold to the Buyer at an Additional Closing an aggregate of $600,000 principal amount of Additional Notes.”
Blackstone Private Equity Strategies Fund (TE) L.P. issued 1,359,375 Class I Units, 1,748,870 Class S Units, 47,313 Class D Units of unit to accredited investors and qualified purchasers for aggregate consideration of approximately $112.6 million.
“Blackstone Private Equity Strategies Fund (TE) L.P. (2) Class I Units Series I 1,359,375 $ 49,134,079 1 Series II — $ — Series III — $ — Class S Units 1,748,870 $ 61,970,519 Class D Units 47,313 $ 1,525,000 Total $ 112,629,598”
Blackstone Private Equity Strategies Fund (TE) L.P. issued 5,706,476 Class I Units, 3,475,094 Class S Units, 829 Class D Units, 69,364 Class N Units of unit to accredited investors and qualified purchasers for aggregate consideration of approximately $334.7 million.
“On May 1, 2026, Blackstone Private Equity Strategies Fund L.P. (the “BXPE U.S.”) and Blackstone Private Equity Strategies Fund (TE) L.P. (the “Feeder” and collectively with BXPE U.S., the “Funds,”) each sold unregistered limited partnership units (the “Units”) for aggregate consideration of approximately $334.7 million (1) and $112.6 million (2) , respectively.”
Blackstone Infrastructure Strategies L.P. issued 4,433,026 Class I Units, 1,475,301 Class S Units, 69,024 Class D Units of unit to accredited investors and qualified purchasers for aggregate consideration of $173.3 million.
“On May 1, 2026, Blackstone Infrastructure Strategies L.P. (the “Fund”) sold unregistered limited partnership units (the “Units”) for aggregate consideration of approximately $173.3 million”
XCF Global, Inc. issued 13,333,340 shares of common stock to EEME Energy SPV I, LLC for aggregate gross proceeds of approximately $2 million at a price per share of $0.15.
“On May 25, 2026, the Company entered into a securities purchase agreement (the “ EEME Agreement ”) with EEME Energy SPV I, LLC (“ EEME ”), pursuant to which the Company agreed to issue 13,333,340 shares (the “ EEME Shares ” and together, with the Brown Stone Shares, the “ Shares ”) of its Common Stock for aggregate gross proceeds of approximately $2 million at a price per share of $0.15.”
XCF Global, Inc. issued 13,333,340 shares of common stock to Brown Stone Capital Ltd. for aggregate gross proceeds of approximately $2 million at a price per share of $0.15.
“On May 22, 2026, XCF Global, Inc. (the “ Company ”), entered into a securities purchase agreement (the “ Brown Stone Agreement ”) with Brown Stone Capital Ltd. (“ Brown Stone ”), pursuant to which the Company agreed to issue 13,333,340 shares (the “ Brown Stone Shares ”) of its Class A common stock, par value $0.0001 (“ Common Stock ”) for aggregate gross proceeds of approximately $2 million at a price per share of $0.15.”
CXApp Inc. issued 26,729,531 shares of common stock of common stock to Avondale Capital, LLC for between $0.126216 and $0.135317 per share.
“CXApp Inc. (the “Company”) issued an aggregate of 26,729,531 shares of common stock to Avondale Capital, LLC (“Avondale”) under a Pre-Paid Purchase #3, dated as of October 17, 2025, which was entered into pursuant to the Securities Purchase Agreement, dated as of March 26, 2025, by and between the Company and Avondale. The shares of common stock were issued between May 15, 2026 and May 27, 2026, at a price between $0.126216 and $0.135317 per share.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.